The reporter, Phil Rogers, submitted samples of his and the dog’s DNA to a random subset of direct-to-consumer DNA companies, including Ancestry.com, MyHeritage DNA and HomeDNA. Many of these companies sent back Bailey’s test as unreadable. However, one did not.
Orig3n — which advertises itself under the banner “What makes you unique?” — says it analyzes customers’ DNA to determine characteristics like strength, intelligence and speed. In return, it provides customers with lifestyle advice related to diet and exercise.
After Mr. Rogers submitted Bailey’s DNA sample to Orig3n, the company returned a seven-page report, which didn’t make any note of the DNA not coming from a human subject. The report said Bailey’s muscle force would be best for quick movements, such as boxing and basketball, NBC 5 Chicago reports.
Orig3n did not respond to NBC 5 Chicago‘s request for comment, which inquired why the company had not detected Bailey was a dog.
More articles on data analytics & precision medicine:
NIH partners with fraternities to recruit ‘All of Us’ participants
Lancaster General Health partners with private equity firm to launch $300M precision medicine fund
7 most interesting questions NIH Director Dr. Francis Collins answered during his Reddit AMA
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
